The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 21, 2022

Filed:

Mar. 23, 2017
Applicant:

Helmholtz Zentrum Muenchen-deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh), Neuherberg, DE;

Inventors:

Elfriede Noessner, Munich, DE;

Ramona Schlenker, Munich, DE;

Stephan Weisz, Freising, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C12N 15/62 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70578 (2013.01); C07K 14/70503 (2013.01); C07K 14/70532 (2013.01); C12N 15/62 (2013.01); C07K 2319/03 (2013.01); C07K 2319/74 (2013.01);
Abstract

The present invention relates to fusion proteins comprising (a) an extracellular domain containing a polypeptide derived from PD-1 or CD40L at its N-terminus; (b) a transmembrane domain; and (c) an intracellular domain containing a polypeptide derived from 4-1BB or CD28 at its C-terminus. Also, fusion proteins with CD28 at the N-terminus and CD40L at the C-terminus are envisaged. The present invention also relates to nucleic acid molecules encoding such fusion proteins, vectors containing such nucleic acid molecules, and host cells containing such vectors. The present invention further relates to methods for producing such host cells. Finally, the present invention relates to pharmaceutical compositions comprising such fusion proteins, nucleic acid molecules, vectors, and/or host cells, particularly for treating diseases or disorders associated with PD-1/PD-L2 or CD40 binding and/or PD-L1/PD-L2 or CD40 expression such as cancer and chronic viral infection.


Find Patent Forward Citations

Loading…